The basis of allotment for the ₹400 crore GSP Crop Science IPO will be announced today, 20 March 2026. Investors can check the IPO allotment status through the official websites of the NSE, BSE, or the IPO’s registrar, MUFG Intime India.
The GSP Crop Science IPO is a book-building issue of ₹400 crore, consisting of a fresh issue of ₹250 crore and an offer for sale of ₹160 crore.
The bidding window was open from March 16, 2026, to March 18, 2026, during which the IPO received a total subscription of 1.61x. The price band is set between ₹304 and ₹320 per share.
The book-running lead managers for the IPO are Equirus Capital Private Limited and Motilal Oswal Investment Advisors Limited, while MUFG Intime India Private Limited (Link Intime) is the registrar.
[18 March, 2026, End of the day]
|
Investor Category |
Subscription (Times) |
|
Qualified Institutional Buyers (QIBs) |
2.66 |
|
Non-Institutional Investors |
3.05 |
|
Retail Individual Investors (RIIs) |
0.40 |
|
Total |
1.61 |
According to media reports, the Grey Market Premium (GMP) of the GSP Crop Science IPO is reported at nil over the IPO price.
The net proceeds from the fresh issue will be used towards the following objectives:
GSP Crop Science is a research-driven agrochemical company with over 40 years of experience in the industry. The company specialises in the development and manufacturing of insecticides, herbicides, fungicides, and plant growth regulators in India.
As of September 30, 2025, the company has secured 524 product registrations across formulations and technical portfolios, granted 102 patents to date, and has 108 additional patent applications under review.
Disclaimer: This news is solely for educational purposes. The securities/investments quoted here are not recommendatory.
To read the RA disclaimer, please click here.